Consolidation treatment of adult acute lymphoblastic leukemia: A prospective, randomized trial comparing allogeneic versus autologous bone marrow transplantation and testing the impact of recombinant interleukin-2 after autologous bone marrow transplantation

Blood

Volumn 86, Issue 4, 1995, Pages 1619-1628

  Attal, M ^a   Blaise, D ^a   Marit, G ^a   Payen, C ^a   Michallet, M ^a   Vernant, J P ^a   Sauvage, C ^a   Troussard, X ^a   Nedellec, G ^a   Pico, J ^a   Huguet, F ^a   Stoppa, A M ^a   Broustet, A ^a   Sotto, J J ^a   Pris, J ^a   Maraninchi, D ^a   Reiffers, J ^a  

^a CHU PURPAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; DAUNORUBICIN; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; RECOMBINANT INTERLEUKIN 2; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CLINICAL PROTOCOL; CLINICAL TRIAL; COLONY FORMING UNIT GM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GRAFT VERSUS HOST REACTION; HLA TYPING; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LEUKEMIA REMISSION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIBLING; SURVIVAL RATE; WHOLE BODY RADIATION;

EID: 0029123732     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v86.4.1619.bloodjournal8641619     Document Type: Article

References (0)